Magnus Persson - 14 Jun 2022 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
Director
Signature
/s/ Donald R. Reynolds, by Power of Attorney
Issuer symbol
AVTX
Transactions as of
14 Jun 2022
Net transactions value
$0
Form type
4
Filing time
16 Jun 2022, 16:01:09 UTC
Previous filing
04 Apr 2022
Next filing
05 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVTX Stock Option (Right to Buy) Award $0 +40,000 $0.000000 40,000 14 Jun 2022 Common Stock 40,000 $0.4410 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest in full on June 14, 2023, subject to the Reporting Person's continued service on such vesting date.